HIV Clinical Updates: New Single-Tablet Regimens
Sign Up to like & getrecommendations! Published in 2019 at "Annals of Pharmacotherapy"
DOI: 10.1177/1060028018793252
Abstract: Objective: To review the pharmacokinetics, safety, common drug-drug interactions (DDIs), and advantages and disadvantages of new single-tablet regimens (STRs) approved since September 2016 for HIV-1 infection. Data Sources: A search using PubMed was conducted (2004… read more here.
Keywords: tablet regimens; clinical updates; single tablet; new single ... See more keywords
De-simplifying single-tablet antiretroviral treatments for cost savings in France: From the patient perspectives to a 6-month follow-up on generics
Sign Up to like & getrecommendations! Published in 2020 at "PLoS ONE"
DOI: 10.1371/journal.pone.0239704
Abstract: In developed countries, most people living with HIV/AIDS are treated with costly brand single-tablet regimens. Given the economic impact, French guidelines recommend using generic antiretroviral therapy when possible to decrease antiretroviral therapy costs. We aimed… read more here.
Keywords: antiretroviral therapy; tablet regimens; brand single; simplifying single ... See more keywords
Patient-reported outcomes among people living with HIV on single- versus multi-tablet regimens: Data from a real-life setting
Sign Up to like & getrecommendations! Published in 2022 at "PLoS ONE"
DOI: 10.1371/journal.pone.0262533
Abstract: Background The use of single-tablet regimens (STRs) in HIV treatment is ubiquitous. However, reintroducing the (generic) components as multi-tablet regimens (MTRs) could be an interesting cost-reducing strategy. It is essential to involve patient-reported outcome measures… read more here.
Keywords: tablet regimens; living hiv; people living; mtr ... See more keywords